98%
921
2 minutes
20
Diabetic nephropathy (DN) is a common chronic complication of diabetes. In this study, we aimed to explore the potential role of lncRNA LINC-00162 in the pathogenic process of DN. LncRNA microarray analysis, real-time PCR, IHC computational analysis and luciferase assay were performed to explore the regulatory relationship among LINC00162, miR-383 and HDAC9. There was an obvious difference between T2D + DN and T2D - DN patients in their levels of eGRF and albuminuria. A significant difference was observed between T2D + DN and T2D - DN groups in terms of their LINC00162 expression. In particular, LINC00162 and HDAC9 were highly expressed, while miR-383 was lowly expressed in tissues derived from the T2D + DN group compared with those in tissues derived from the T2D - DN group. MiR-383 was able to bind to LINC00162, while HDAC9 was a direct downstream target of miR-383 with a complementary miR-383 binding site located in the 3' UTR of HDAC9. LINC00162 reduced miR-383 expression and further up-regulated HDAC9 expression, while miR-383 mimics reduced HDAC9 expression under a dose-dependent manner. In summary, we suggested for the first time that down-regulation of LINC00162 was associated with the development of DN in T2D via the up-regulation of miR-383 expression and reduction of HDAC9 expression.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/21691401.2020.1773487 | DOI Listing |
Diabetes Metab J
September 2025
Department of Nephrology, The Second Xiangya Hospital, Central South University, Key Lab of Kidney Disease and Blood Purification in Hunan, Changsha, China.
Background: Contrast-induced acute kidney injury (CIAKI) is the third cause of hospital-acquired acute kidney injury and diabetes mellitus (DM) was identified as a risk factor for CIAKI. However, the molecular mechanism underlying DM-CIAKI remains unclear, which needs further investigation.
Methods: DM-CIAKI models of mice and cells were established.
FASEB J
September 2025
Department of Gastroenterology, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent hepatic metabolic disorder with a rising global incidence. Epigenetic modifications-such as methylation, acetylation, phosphorylation, and ubiquitination-play critical roles in the initiation and progression of MASLD. This study utilized two datasets, GSE89632 and GSE202379.
View Article and Find Full Text PDFBMC Genomics
July 2025
School of Animal Sciences, Virginia Tech, Blacksburg, VA, 24061, USA.
Background: Intramuscular fat refers to the white adipose tissue deposited between muscle fibers, and its quantity and distribution directly impact the quality and value of beef. Compared to subcutaneous fat, intramuscular fat develops later and accumulates more slowly in cattle. The reasons for the delayed development and slower growth of intramuscular fat in cattle remain unclear.
View Article and Find Full Text PDFSignal Transduct Target Ther
July 2025
Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Research Unit of Hematologic Malignancies Genomics and Translational Research of Chinese Academy of Medical Sciences, Ruijin Hospital, Shanghai Jiao Tong Unive
MEF2D fusions are found in a special subtype of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) with poor prognosis. In this study, we conducted high-throughput drug screenings using cell line and ex vivo cell model harboring, respectively, MEF2D::HNRNPUL1(MH) and MEF2D::BCL9(MB), the two major MEF2D fusions. We identified CUDC-907 as a highly potent dual-target inhibitor of PI3K/HDAC, demonstrating remarkable efficacy in inducing robust lethality while maintaining selectivity for MEF2D fusion-expressing cells.
View Article and Find Full Text PDFBackground: Environmental factors play a role in AD pathology and are mediated by changes in DNA methylation levels.
Methods And Results: We investigated whole genome methylation sequencing (WGMS) data from the blood of participants with mild cognitive impairment (MCI, =99), late onset dementia due to Alzheimer's disease (AD, =109), and who are cognitively unimpaired (CU, =174) to test for differential methylation in 812 genes with roles in epigenetic regulation ( , DNA methylation and demethylation, chromatin remodeling, histone modification, and RNA modification) curated from the EpiFactors 2.1 database.